HomeLOVE • CVE
add
Cannara Biotech Inc
Previous close
$1.28
Day range
$1.25 - $1.32
Year range
$0.52 - $1.46
Market cap
119.55M CAD
Avg Volume
54.26K
P/E ratio
8.97
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Revenue | 26.46M | 34.57% |
Operating expense | 6.08M | -0.36% |
Net income | 3.31M | 196.17% |
Net profit margin | 12.53 | 171.48% |
Earnings per share | — | — |
EBITDA | 7.31M | 1,344.34% |
Effective tax rate | 29.92% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.06M | 61.48% |
Total assets | 161.41M | 10.69% |
Total liabilities | 67.22M | 1.10% |
Total equity | 94.19M | — |
Shares outstanding | 91.43M | — |
Price to book | 1.24 | — |
Return on assets | 8.92% | — |
Return on capital | 10.17% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2025info | Y/Y change |
|---|---|---|
Net income | 3.31M | 196.17% |
Cash from operations | -2.55M | -192.27% |
Cash from investing | -1.40M | -29.90% |
Cash from financing | -1.26M | -5.17% |
Net change in cash | -5.21M | -1,159.73% |
Free cash flow | -6.98M | -127.83% |
About
Founded
2017
Website
Employees
13
